SUVRETTA CAPITAL MANAGEMENT, LLC
13F Reported Value
ⓘ$5.5B
incl. option notional
Equity Holdings
ⓘ$4.8B
Option Notional
ⓘ$709.4M
$709.4M puts / $0 calls
Holdings
96
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 96 positions worth $5.5B in its Form 13F-HR for Q2 2026 — $4.8B in common stock plus $709.4M of put/call option positions (reported at underlying notional value, not premium at risk), led by $SPY (SPDR S&P 500 ETF TRUST) puts, followed by $MANE and $ARQT. During the quarter the fund opened 21 new positions and exited 14 — including a new stake in $AVLN and a full exit from $APLS. The portfolio is most concentrated in Healthcare (59.7% of disclosed assets). All figures are sourced directly from SUVRETTA CAPITAL MANAGEMENT, LLC’s Form 13F-HR filing with the SEC under CIK 1569064.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$709.4M950,000 sh - —
Quality
$512.5M4,168,970 sh - 62.9#675
Quality
$326.1M12,437,000 sh - 47.8
Quality
$204.2M7,070,000 sh - —
Quality
$173.5M1,135,406 sh - —
Quality
$156.9M4,515,531 sh - —
Quality
$154.5M11,548,351 sh - —
Quality
$153.1M10,286,937 sh - 79.8
Quality
$149.4M257,240 sh - 8.5
Quality
$147.3M4,776,423 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 SPDR S&P 500 ETF TRUST$SPYPUT | — | $709.4M | 950,000 |
 Veradermics, Inc$MANE | — | $512.5M | 4,168,970 |
 Arcutis Biotherapeutics, Inc.$ARQT | 62.9#675 | $326.1M | 12,437,000 |
 Legend Biotech Corp$LEGN | 47.8 | $204.2M | 7,070,000 |
 PALVELLA THERAPEUTICS, INC.$PVLA | — | $173.5M | 1,135,406 |
 ArriVent BioPharma, Inc.$AVBP | — | $156.9M | 4,515,531 |
 Benitec Biopharma Inc.$BNTC | — | $154.5M | 11,548,351 |
 Biohaven Ltd.$BHVN | — | $153.1M | 10,286,937 |
 ADVANCED MICRO DEVICES INC$AMD | 79.8 | $149.4M | 257,240 |
 Arcus Biosciences, Inc.$RCUS | 8.5 | $147.3M | 4,776,423 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of SUVRETTA CAPITAL MANAGEMENT, LLC's 96 positions.
Showing top 10 of 96 holdings.
Sector Allocation
Healthcare
$2.8B
Technology
$935.9M
Consumer Discretionary
$452.3M
Financials
$234.5M
Other
$148.0M
Materials
$78.4M
Communication Services
$58.2M
Consumer Staples
$6.6M
Full Holdings — SUVRETTA CAPITAL MANAGEMENT, LLC (Q2 2026)
All 96 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $SPYPUT | SPDR S&P 500 ETF TRUST | $709.4M | — | +171% | — |
| 2 | $MANE | Veradermics, Inc | $512.5M | 10.8% | +0% | — |
| 3 | $ARQT | Arcutis Biotherapeutics, Inc. | $326.1M | 6.8% | +1% | 62.9 |
| 4 | $LEGN | Legend Biotech Corp | $204.2M | 4.3% | -7% | 47.8 |
| 5 | $PVLA | PALVELLA THERAPEUTICS, INC. | $173.5M | 3.6% | -2% | — |
| 6 | $AVBP | ArriVent BioPharma, Inc. | $156.9M | 3.3% | +3% | — |
| 7 | $BNTC | Benitec Biopharma Inc. | $154.5M | 3.3% | +0% | — |
| 8 | $BHVN | Biohaven Ltd. | $153.1M | 3.2% | +0% | — |
| 9 | $AMD | ADVANCED MICRO DEVICES INC | $149.4M | 3.1% | +0% | 79.8 |
| 10 | $RCUS | Arcus Biosciences, Inc. | $147.3M | 3.1% | -5% | 8.5 |
| 11 |  $TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $145.5M | 3.1% | +2% | — |
| 12 |  $NVDA | NVIDIA CORP | $144.2M | 3.0% | +25% | 85.9 |
| 13 |  $EYPT | EyePoint, Inc. | $118.6M | 2.5% | +0% | 3.5 |
| 14 |  $SYY | SYSCO CORP | $118.0M | 2.5% | +22% | 54.7 |
| 15 |  $GE | GENERAL ELECTRIC CO | $116.0M | 2.4% | +0% | 73.8 |
| 16 |  $IMTX | Immatics N.V. | $113.4M | 2.4% | +0% | — |
| 17 |  $MGM | MGM Resorts International | $111.2M | 2.3% | +8% | 55.2 |
| 18 |  $META | Meta Platforms, Inc. | $99.0M | 2.1% | +4% | 79.6 |
| 19 |  $CAPR | CAPRICOR THERAPEUTICS, INC. | $98.6M | 2.1% | +7% | 13.6 |
| 20 |  $KURA | Kura Oncology, Inc. | $94.1M | 2.0% | +0% | 27.6 |
| 21 |  $GLUE | Monte Rosa Therapeutics, Inc. | $85.9M | 1.8% | -16% | 30.3 |
| 22 |  $AVLN | Avalyn Pharma Inc. | $82.4M | 1.7% | NEW | — |
| 23 |  $HD | HOME DEPOT, INC. | $79.7M | 1.7% | +2% | 60.3 |
| 24 |  $HUT | Hut 8 Corp. | $77.3M | 1.6% | NEW | 37.4 |
| 25 |  $COF | CAPITAL ONE FINANCIAL CORP | $66.8M | 1.4% | +10% | 62.4 |
| 26 |  $VMC | Vulcan Materials CO | $63.4M | 1.3% | +18% | 63.5 |
| 27 |  $FERG | Ferguson Enterprises Inc. /DE/ | $58.6M | 1.2% | +16% | 52.2 |
| 28 |  $ZURA | Zura Bio Ltd | $55.7M | 1.2% | +4% | — |
| 29 |  $IFRX | InflaRx N.V. | $51.4M | 1.1% | +189% | — |
| 30 |  $AURA | Aura Biosciences, Inc. | $51.2M | 1.1% | +65% | — |
| 31 | — | FAETH THERAPEUTICS INC - COM NEW | $50.5M | 1.1% | +5747% | — |
| 32 | — | ADVISORSHARES TR - PURE US CANN ETF | $49.5M | 1.0% | +8% | — |
| 33 |  $AMZN | AMAZON COM INC | $48.8M | 1.0% | -19% | 68.7 |
| 34 |  $REPL | Replimune Group, Inc. | $48.6M | 1.0% | +4% | — |
| 35 |  $APH | AMPHENOL CORP /DE/ | $47.5M | 1.0% | NEW | 79.3 |
| 36 |  $SPOT | Spotify Technology S.A. | $46.7M | 1.0% | +9155% | — |
| 37 |  $CTNM | Contineum Therapeutics, Inc. | $46.6M | 1.0% | +0% | — |
| 38 |  $APO | Apollo Global Management, Inc. | $45.3M | 0.9% | -1% | 52.1 |
| 39 |  $BAC | BANK OF AMERICA CORP /DE/ | $45.0M | 0.9% | -39% | 67.6 |
| 40 | — | ROUNDHILL ETF TRUST - MEMORY ETF | $44.5M | 0.9% | NEW | — |
| 41 |  $CRNX | Crinetics Pharmaceuticals, Inc. | $44.4M | 0.9% | +14% | 25.5 |
| 42 |  $CBRS | Cerebras Systems Inc. | $38.0M | 0.8% | NEW | — |
| 43 |  $DKS | DICK'S SPORTING GOODS, INC. | $34.3M | 0.7% | NEW | 63 |
| 44 |  $AVGO | Broadcom Inc. | $31.6M | 0.7% | NEW | 84.5 |
| 45 |  $CMPX | Compass Therapeutics, Inc. | $30.9M | 0.7% | -1% | 28.1 |
| 46 |  $LXEO | Lexeo Therapeutics, Inc. | $29.7M | 0.6% | +411% | — |
| 47 |  $UNH | UNITEDHEALTH GROUP INC | $26.7M | 0.6% | -36% | 62.7 |
| 48 |  $PROK | PROKIDNEY CORP. | $25.2M | 0.5% | +0% | 25.8 |
| 49 |  $WHWK | Whitehawk Therapeutics, Inc. | $19.7M | 0.4% | +16% | 26.4 |
| 50 |  $SPCX | SPACE EXPLORATION TECHNOLOGIES CORP | $17.3M | 0.4% | NEW | — |
| 51 |  $MLM | MARTIN MARIETTA MATERIALS INC | $15.0M | 0.3% | NEW | 62.9 |
| 52 |  $FULC | Fulcrum Therapeutics, Inc. | $13.5M | 0.3% | -44% | 32.9 |
| 53 |  $PLNT | Planet Fitness, Inc. | $11.5M | 0.2% | NEW | 67.6 |
| 54 |  $BE | Bloom Energy Corp | $10.2M | 0.2% | NEW | 66.2 |
| 55 |  $KARD | Kardigan, Inc. | $9.5M | 0.2% | NEW | — |
| 56 |  $CVS | CVS HEALTH Corp | $8.7M | 0.2% | NEW | 59.4 |
| 57 |  $MOLN | MOLECULAR PARTNERS AG | $8.6M | 0.2% | +0% | — |
| 58 |  $AVR | Anteris Technologies Global Corp. | $8.4M | 0.2% | +0% | — |
| 59 |  $DXCM | DEXCOM INC | $6.9M | 0.1% | +222% | 76 |
| 60 |  $TMO | THERMO FISHER SCIENTIFIC INC. | $6.7M | 0.1% | +0% | 65.1 |
| 61 |  $CNC | CENTENE CORP | $6.4M | 0.1% | NEW | 58.2 |
| 62 |  $ABT | ABBOTT LABORATORIES | $6.1M | 0.1% | +0% | 65.5 |
| 63 |  $BSX | BOSTON SCIENTIFIC CORP | $6.0M | 0.1% | +13% | 77.5 |
| 64 |  $ISRG | INTUITIVE SURGICAL INC | $5.4M | 0.1% | +20% | 79.9 |
| 65 |  $DHR | DANAHER CORP /DE/ | $5.1M | 0.1% | -27% | 64.8 |
| 66 |  $MLYS | Mineralys Therapeutics, Inc. | $4.7M | 0.1% | -89% | — |
| 67 |  $CLDX | Celldex Therapeutics, Inc. | $4.5M | 0.1% | NEW | 8.4 |
| 68 |  $MSLE | Satellos Bioscience Inc. | $3.7M | 0.1% | +0% | — |
| 69 |  $COR | Cencora, Inc. | $3.5M | 0.1% | +0% | 61.1 |
| 70 | — | TRULIEVE CANNABIS CORP - SUB VTG SHS | $3.5M | 0.1% | NEW | — |
| 71 |  $ABEO | ABEONA THERAPEUTICS INC. | $3.1M | 0.1% | -81% | 23.7 |
| 72 |  $NTRA | Natera, Inc. | $2.7M | 0.1% | +0% | 53.5 |
| 73 |  $JNJ | JOHNSON & JOHNSON | $2.0M | 0.0% | -67% | 69 |
| 74 |  $LRCX | LAM RESEARCH CORP | $1.9M | 0.0% | NEW | 79.4 |
| 75 |  $MSFT | MICROSOFT CORP | $1.9M | 0.0% | +0% | 79.8 |
| 76 |  $SYK | STRYKER CORP | $1.8M | 0.0% | +0% | 72.1 |
| 77 |  $EW | Edwards Lifesciences Corp | $1.7M | 0.0% | +0% | 69.4 |
| 78 |  $MDLN | Medline Inc. | $1.7M | 0.0% | +0% | 62.5 |
| 79 |  $PFGC | Performance Food Group Co | $1.6M | 0.0% | -96% | 55.7 |
| 80 |  $SNOW | Snowflake Inc. | $1.4M | 0.0% | NEW | 54.9 |
| 81 |  $IQV | IQVIA HOLDINGS INC. | $1.4M | 0.0% | +0% | 61.4 |
| 82 |  $MCK | MCKESSON CORP | $1.4M | 0.0% | +0% | 63.4 |
| 83 |  $HCA | HCA Healthcare, Inc. | $1.2M | 0.0% | +0% | 68.9 |
| 84 |  $WAT | WATERS CORP /DE/ | $1.2M | 0.0% | +0% | 60.4 |
| 85 |  $GOOGL | Alphabet Inc. | $1.2M | 0.0% | NEW | 78.2 |
| 86 |  $GWW | W.W. GRAINGER, INC. | $1.0M | 0.0% | -23% | 61.8 |
| 87 |  $IONS | IONIS PHARMACEUTICALS INC | $856,332 | 0.0% | +0% | 23.4 |
| 88 |  $USFD | US Foods Holding Corp. | $707,570 | 0.0% | -98% | 58.4 |
| 89 |  $A | AGILENT TECHNOLOGIES, INC. | $662,822 | 0.0% | +0% | 67.1 |
| 90 |  $VLTO | Veralto Corp | $485,523 | 0.0% | +0% | 65.5 |
| 91 |  $RMD | RESMED INC | $465,763 | 0.0% | +0% | 74.3 |
| 92 |  $STE | STERIS plc | $322,172 | 0.0% | +0% | — |
| 93 |  $SRPT | Sarepta Therapeutics, Inc. | $321,447 | 0.0% | +0% | 47.3 |
| 94 |  $ZBH | ZIMMER BIOMET HOLDINGS, INC. | $280,653 | 0.0% | +0% | 65.7 |
| 95 |  $CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $229,058 | 0.0% | NEW | 43.8 |
| 96 |  $INM | InMed Pharmaceuticals Inc. | $155,000 | 0.0% | NEW | 13.1 |
New Positions (21)
$AVLN Avalyn Pharma Inc.$82.4M$HUT Hut 8 Corp.$77.3M$APH AMPHENOL CORP /DE/$47.5M$CBRS Cerebras Systems Inc.$38.0M$DKS DICK'S SPORTING GOODS, INC.$34.3M$AVGO Broadcom Inc.$31.6M$SPCX SPACE EXPLORATION TECHNOLOGIES CORP$17.3M$MLM MARTIN MARIETTA MATERIALS INC$15.0M$PLNT Planet Fitness, Inc.$11.5M$BE Bloom Energy Corp$10.2M$KARD Kardigan, Inc.$9.5M$CVS CVS HEALTH Corp$8.7M$CNC CENTENE CORP$6.4M$CLDX Celldex Therapeutics, Inc.$4.5MExited Positions (14)
$APLS Apellis Pharmaceuticals, Inc.
$KALV KalVista Pharmaceuticals, Inc.
$ERAS Erasca, Inc.
$LTH Life Time Group Holdings, Inc.
$WING Wingstop Inc.
$COHR COHERENT CORP.
$MDT Medtronic plc
$KZR Kezar Life Sciences, Inc.
$MTD METTLER TOLEDO INTERNATIONAL INC/
$TSLA Tesla, Inc.
$TLN Talen Energy Corp
$VST Vistra Corp.
$RBLX Roblox Corp
$VRDN Viridian Therapeutics, Inc.\DEBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for SUVRETTA CAPITAL MANAGEMENT, LLC including:
Track SUVRETTA CAPITAL MANAGEMENT, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for SUVRETTA CAPITAL MANAGEMENT, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: SUVRETTA CAPITAL MANAGEMENT, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For SUVRETTA CAPITAL MANAGEMENT, LLC (SEC CIK: 1569064), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in SUVRETTA CAPITAL MANAGEMENT, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.